Abbott stock slumps on earnings. What’s weighing on the medical devices maker?

Abbott reports fourth-quarter sales that miss analysts’ estimates.

Abbott's Q4 Earnings Meet Estimates, Revenues Miss, Stock Falls

ABT's Q4 earnings meet estimates but revenues miss, sending shares down as strong device growth is offset by weaker nutrition ...

Abbott Labs Stock Hits 52-Week Low As Outlook Disappoints

Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast ...

GE Aerospace stock slumps, Abbott falls on Q4 sales, Mobileye's guidance

Morning Brief Host Julie Hyman tracks several of the day's top trending stock tickers, including GE Aerospace (GE) shares ...
Medical Device Network

Abbott’s stock falls by nearly 11% following Q4 sales miss

Abbott’s stock has fallen by over 7% despite reporting strong fiscal year 2025 (FY25) revenues of $44.32bn, representing a ...

Abbott Laboratories stock hits 52-week low at $107.27

Abbott Laboratories stock has reached a 52-week low, closing at $107.27. This marks a notable point for the healthcare company, as it navigates a challenging market environment. Over the past year, ...

Abbott slumps over 8% after missing Q4 revenue targets, lower Q1 forecast

The medical device maker announced it anticipates first quarter adjusted profits per share between $1.12 and $1.18, trailing ...
The Edge Singapore

Abbott sinks after 1Q profit forecast falls short

Abbott Laboratories forecast a 1Q profit that was lower than Wall Street expected and missed 4Q sales estimates after its ...
Investing.com South Africa

Abbott falls as fourth quarter revenue misses expectations

Investing.com -- Abbott Laboratories (NYSE:ABT) reported fourth-quarter earnings that met expectations but missed on revenue, ...

These stocks are today’s movers: Intel, GE Aerospace, Moderna, Abbott, Arista Networks, Mobileye, McCormick, and more

Intel shares rise slightly ahead of the chip maker’s fourth-quarter earnings, due out after the close of trading Thursday.

Top Wall Street Forecasters Revamp Abbott Expectations Ahead Of Q4 Earnings

Abbott received CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms. Shares of Abbott fell 0.3% to close at $120.73 on Wed ...